These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34040938)

  • 1. Survival of Left-to-Right Shunt Repair in Children with Pulmonary Arterial Hypertension at a Tertiary Hospital in a Low-to-Middle-Income Country.
    Arafuri N; Murni IK; Idris NS; Uiterwaal CSPM; Savitri AI; Nugroho S; Noormanto N
    Glob Heart; 2021 Apr; 16(1):25. PubMed ID: 34040938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary survival outcomes of congenital systemic-to-pulmonary shunt in children with borderline pulmonary vascular resistant index compared to Eisenmenger syndrome.
    Chaiwangyen N; Vijarnsorn C; Chungsomprasong P; Chanthong P; Kanjanauthai S; Thammasate P; Pacharapakornpong T; Bositthipichet D; Sengsim J; Soongswang J; Tocharoenchok T; Nitiyarom E; Tantiwongkosri K; Subtaweesin T; Durongpisitkul K
    Sci Rep; 2024 Jul; 14(1):16867. PubMed ID: 39043775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 4. Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts.
    Vijarnsorn C; Durongpisitkul K; Chungsomprasong P; Bositthipichet D; Ketsara S; Titaram Y; Chanthong P; Kanjanauthai S; Soongswang J
    PLoS One; 2018; 13(4):e0195092. PubMed ID: 29664959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of operability in children with severe pulmonary hypertension associated with congenital heart disease.
    Xi SB; Wang SS; Qian MY; Xie YM; Li JJ; Zhang ZW
    Chin Med J (Engl); 2019 Apr; 132(7):811-818. PubMed ID: 30789367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.
    Galie N; Manes A; Palazzini M; Negro L; Marinelli A; Gambetti S; Mariucci E; Donti A; Branzi A; Picchio FM
    Drugs; 2008; 68(8):1049-66. PubMed ID: 18484798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.
    D'Alto M; Romeo E; Argiento P; Correra A; Santoro G; Gaio G; Sarubbi B; Calabrò R; Russo MG
    Int J Cardiol; 2013 Oct; 168(4):3797-801. PubMed ID: 23850317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term course of pulmonary arterial hypertension in adults with congenital heart disease under targeted therapy: a retrospective analysis of a single tertiary center.
    Strack K; Freilinger S; Busse AJ; Ewert P; Hauser M; Huntgeburth M; Kaemmerer AS; Nagdyman N; Schopen J; Kaemmerer H; von Scheidt F
    Cardiovasc Diagn Ther; 2022 Oct; 12(5):655-670. PubMed ID: 36329967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Artery Hypertension as A Risk Factor for Long-Term Survival after Heart Transplantation.
    Matkovic M; Milicevic V; Bilbija I; Aleksic N; Cubrilo M; Nestorovic E; Antic A; Zlatkovic M; Velinovic M; Putnik S
    Heart Surg Forum; 2021 Jun; 24(3):E544-E549. PubMed ID: 34173749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of composite clinical worsening events on outcome of patients with pulmonary arterial hypertension associated with congenital heart disease].
    Xu ZY; Zhang HS; Li QQ; Zhang C; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):282-288. PubMed ID: 35340148
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet distribution width and mean platelet volume in children with pulmonary arterial hypertension secondary to congenital heart disease with left-to-right shunt: new indices of severity?
    Arslan D; Cimen D; Guvenc O; Kaya F; Sert A; Oran B
    Pediatr Cardiol; 2013 Apr; 34(4):1013-6. PubMed ID: 23254645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of pulmonary vascular disease associated with congenital left-to-right shunts: A single-center experience.
    Nawaytou H; Lakkaraju R; Stevens L; Reddy VM; Swami N; Keller RL; Teitel DF; Fineman JR
    J Thorac Cardiovasc Surg; 2024 May; ():. PubMed ID: 38763305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
    Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
    Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups.
    Manes A; Palazzini M; Leci E; Bacchi Reggiani ML; Branzi A; Galiè N
    Eur Heart J; 2014 Mar; 35(11):716-24. PubMed ID: 23455361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects.
    Li Q; Dimopoulos K; Zhang C; Zhu Y; Liu Q; Gu H
    Pediatr Cardiol; 2018 Apr; 39(4):757-762. PubMed ID: 29426959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
    Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
    Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
    Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
    J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing demographics of pulmonary arterial hypertension in congenital heart disease.
    Mulder BJ
    Eur Respir Rev; 2010 Dec; 19(118):308-13. PubMed ID: 21119189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.